Sleep Apnea Oral Appliances Market - Global Forecast To 2030
商品番号 : SMB-20207
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年5月 |
| ページ数 | 265 |
| 図表数 | 362 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、睡眠時無呼吸症候群（SAS）口腔内装置市場を、製品、性別、購入タイプ、年齢層、流通チャネル、エンドユーザー、地域に基づいて分析しています。また、市場の成長に影響を与える要因（促進要因、抑制要因、機会、課題など）を分析するとともに、市場リーダー企業の競争環境の詳細を提供しています。さらに、ミクロ市場の成長傾向を分析し、5つの主要地域（および各地域に所在する各国）における市場セグメントの収益予測も提供しています。
The global sleep apnea oral appliances market is projected to reach USD 0.8 billion by 2030 from USD 0.5 billion in 2025, at a CAGR of 9.8% during the forecast period.
世界の睡眠時無呼吸症候群の口腔内装置市場は、予測期間中に9.8%のCAGRで成長し、2025年の5億米ドルから2030年には8億米ドルに達すると予測されています
The market is experiencing growth due to a rise in lifestyle-related disorders such as diabetes, hypertension, and obesity, which can lead to obstructive sleep apnea and make it difficult for patients to breathe. There is also a growing awareness of sleep apnea and its management and treatment options. Furthermore, leading players in the industry are introducing innovative products and expanding their portfolios. These companies offer a variety of advanced, non-invasive oral appliances that are adjustable to meet patients’ needs better.
糖尿病、高血圧、肥満といった生活習慣病の増加により、市場は成長を遂げています。これらの生活習慣病は閉塞性睡眠時無呼吸症を引き起こし、患者の呼吸を困難にする可能性があります。また、睡眠時無呼吸症とその管理・治療オプションに対する認識も高まっています。さらに、業界の主要企業は革新的な製品を導入し、ポートフォリオを拡大しています。これらの企業は、患者のニーズに合わせて調整可能な、高度で非侵襲的な様々な口腔装置を提供しています。
By end user, the home care settings/individuals segment is expected to dominate the market during the forecast period.
By end users, the sleep apnea appliances market is segmented into clinics, hospitals, and home care settings/individuals. The home care settings/individuals segment accounted for the largest share of the market in 2024. The key factor contributing to market growth in this segment includes the preference of adopting sleep apnea devices in these settings owing to ease of convenience, remote availability, and cost-efficiency compared to hospitalization. These devices are covered by insurance or reimbursement policies. The home care setting is a growing market due to the increasing prevalence of sleep apnea, particularly in developed regions like North America and Europe. This rise is primarily attributed to the lifestyle choices common in these areas. Additionally, the accessibility of home sleep apnea tests is a significant factor contributing to the growth of the sleep apnea oral appliances market.
By distribution channel, the retail pharmacies segment accounted for the largest market share in 2024.
By distribution channel, the sleep apnea oral appliances market is divided into online pharmacies, retail pharmacies, and hospital pharmacies & dental clinics. Among these, the retail pharmacies segment accounted for the largest market share in 2024 owing to the increasing availability of oral sleep apnea appliances in retail pharmacies and the rising establishment of these settings in emerging markets. There is a growing awareness of the risks associated with undiagnosed sleep apnea, leading to an increased demand for oral appliances. This has resulted in zero waiting times at retail pharmacies, which offer a variety of devices that vary in affordability and quality.
The Asia Pacific region is expected to grow at the highest CAGR during the forecast period.
The global sleep apnea oral appliances market is segmented into five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is the fastest-growing regional sleep apnea organ appliance market. The key factors contributing to the high growth rate of the Asia Pacific market are the presence of manufacturing & distribution companies in the region. Some key players have recently expanded their presence in the Asia Pacific by setting up a manufacturing plant for oral appliances. Additionally, advancements in infrastructure and technology in the healthcare sector in the Asia Pacific market are increasing.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–40%, Tier 2–50%, and Tier 3– 10%
- By Designation: C-level–48%, Director-level–37% and Others–15%
- By Region: North America–46%, Europe–26%, Asia Pacific–15%, Latin America- 6%, the Middle East & Africa – 4%, and GCC Countries – 3%
Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The leading players operating in the sleep apnea oral appliances market are SomnoMed (Australia), Resmed (US), ProSomnus Sleep Technologies (US), DynaFlex (US), Vivos Therapeutics, Inc. (US), OpenAirway (Canada), Panthera Dental (Canada), Airway Management (US), Apnea Sciences (US), OravanOSA (US), Myerson LLC (US), and Braebon Medical Corporation (Canada).
Research Coverage
This report studies the sleep apnea oral appliances market based on product, gender, purchase type, age group, distribution channel, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning their growth trends. It forecasts the revenue of the market segments about five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will help established and new or smaller firms understand the market dynamics, allowing them to capture a larger market share. Companies that purchase the report can implement one or a combination of the strategies mentioned below to strengthen their market presence.
This report provides insights on the following pointers:
- Analysis of key drivers (Large pool of undiagnosed sleep apnea patients globally, growing awareness about effects of untreated sleep apnea among patients, rising usage of oral appliances among patients with mild-to-moderate sleep apnea, and the increasing number of companies in sleep apnea devices and oral appliances market), restraints (high prices of customized oral appliances, alternative therapies and medications for sleep apnea, risks associated with oral appliance therapy for obstructive sleep apnea), opportunities (growing demand for home sleep apnea tests as cost-saving measures; increasing focus on telemedicine, mhealth, and AI; poor compliance associated with CPAP) and challenges (complex referral pathways and long waiting periods) influencing the growth of the sleep apnea oral appliances market)
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the sleep apnea oral appliances market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the sleep apnea oral appliances market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the sleep apnea oral appliances market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
Table of Contents
1 INTRODUCTION 28
1.1 STUDY OBJECTIVES 28
1.2 MARKET DEFINITION 28
1.2.1 INCLUSIONS & EXCLUSIONS 29
1.3 MARKET SCOPE 30
1.3.1 MARKETS COVERED & GEOGRAPHIC SPREAD 30
1.3.2 YEARS CONSIDERED 31
1.3.3 CURRENCY CONSIDERED 31
1.4 MARKET STAKEHOLDERS 31
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH DATA 32
2.1.1 SECONDARY DATA 33
2.1.1.1 Key data from secondary sources 34
2.1.2 PRIMARY DATA 34
2.1.2.1 Primary sources 35
2.1.2.2 Key industry insights 36
2.1.2.3 Key data from primary sources 36
2.1.2.4 Breakdown of primary interviews 38
2.2 MARKET SIZE ESTIMATION 38
2.2.1 BOTTOM-UP APPROACH 39
2.2.1.1 Approach 1: Company revenue estimation approach 39
2.2.1.2 Approach 2: Presentations of companies and primary interviews 39
2.2.1.3 Approach 3: Primary interviews 40
2.2.1.4 Approach 4: Growth Forecast 40
2.2.1.5 CAGR projections 40
2.2.2 TOP-DOWN APPROACH 41
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 42
2.4 RESEARCH LIMITATIONS 43
2.5 RESEARCH ASSUMPTIONS 43
2.5.1 STUDY-RELATED ASSUMPTIONS 43
2.5.2 GROWTH RATE ASSUMPTIONS 44
2.6 RISK ASSESSMENT 45
3 EXECUTIVE SUMMARY 46
4 PREMIUM INSIGHTS 51
4.1 SLEEP APNEA ORAL APPLIANCES MARKET OVERVIEW 51
4.2 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2025 VS. 2030 52
4.3 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT AND COUNTRY (2024) 53
4.4 GEOGRAPHIC GROWTH OPPORTUNITIES 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
5.2.1 DRIVERS 55
5.2.1.1 Large pool of undiagnosed sleep apnea patients 55
5.2.1.2 Growing awareness associated with effects of untreated sleep apnea 56
5.2.1.3 Increasing usage of oral appliances among patients with mild-to-moderate sleep apnea 57
5.2.1.4 Entry of established companies with advanced sleep apnea oral solutions 58
5.2.2 RESTRAINTS 58
5.2.2.1 High price of customized oral appliances 58
5.2.2.2 Alternative therapies & medications for sleep apnea 59
5.2.2.3 Risks associated with oral appliance therapy for obstructive sleep apnea 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Rising demand for at-home sleep apnea tests 59
5.2.3.2 Increasing importance of telemedicine, mHealth, and AI 60
5.2.3.3 Poor compliance and low adherence associated with CPAP 61
5.2.4 CHALLENGES 62
5.2.4.1 Complex referral pathways and long waiting periods 62
5.3 PRICING ANALYSIS 62
5.3.1 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023−2025 62
5.3.2 AVERAGE SELLING PRICE OF SLEEP APNEA ORAL PRODUCTS, BY KEY PLAYER, 2023−2025 63
5.3.3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION, 2023−2025 64
5.4 VALUE CHAIN ANALYSIS 65
5.5 SUPPLY CHAIN ANALYSIS 66
5.6 ECOSYSTEM ANALYSIS 67
5.7 PORTER’S FIVE FORCES ANALYSIS 68
5.7.1 THREAT OF NEW ENTRANTS 69
5.7.2 THREAT OF SUBSTITUTES 69
5.7.3 BARGAINING POWER OF SUPPLIERS 69
5.7.4 BARGAINING POWER OF BUYERS 69
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 69
5.8 REGULATORY ANALYSIS 70
5.8.1 REGULATORY LANDSCAPE 70
5.8.1.1 North America 70
5.8.1.1.1 US 70
5.8.1.1.1.1 Reimbursement scenario in US 71
5.8.1.1.2 Canada 72
5.8.1.2 Europe 72
5.8.1.3 Asia Pacific 73
5.8.1.3.1 Japan 73
5.8.1.3.2 China 74
5.8.1.3.3 India 75
5.8.1.3.4 Australia 75
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
5.8.2.1 North America 76
5.8.2.2 Europe 76
5.8.2.3 Asia Pacific 77
5.8.2.4 Latin America 78
5.8.2.5 Middle East & Africa 78
5.9 TRADE ANALYSIS 78
5.9.1 TRADE ANALYSIS FOR INSTRUMENTS & APPLIANCES USED
IN DENTAL SCIENCES 78
5.10 PATENT ANALYSIS 80
5.11 KEY CONFERENCES & EVENTS, 2025−2026 81
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82
5.13 KEY STAKEHOLDERS & BUYING CRITERIA 83
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 83
5.13.2 BUYING CRITERIA 84
5.14 IMPACT OF GENERATIVE AI ON SLEEP APNEA ORAL APPLIANCES MARKET 84
5.14.1 INTRODUCTION 85
5.14.2 MARKET POTENTIAL FOR SLEEP APNEA ORAL APPLIANCES 85
5.14.3 FUTURE OF GENERATIVE AI IN SLEEP APNEA ORAL APPLIANCES MARKET 86
5.15 INVESTMENT & FUNDING SCENARIO 87
5.16 TECHNOLOGY ANALYSIS 87
5.16.1 KEY TECHNOLOGIES 87
5.16.1.1 Mandibular advancement devices 87
5.16.2 ADJACENT TECHNOLOGIES 88
5.16.2.1 Daytime-nighttime appliances 88
5.17 END-USER PERCEPTION ANALYSIS 88
5.18 PURCHASE DECISION-MAKING PROCESS 89
5.18.1 INTRODUCTION 89
5.18.1.1 Need recognition 89
5.18.1.2 Gathering information 90
5.18.1.3 Evaluating alternatives 90
5.19 TRUMP TARIFF IMPACT ON SLEEP APNEA ORAL APPLIANCES MARKET 92
5.19.1 INTRODUCTION 92
5.19.2 KEY TARIFF RATES 93
6 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT 94
6.1 INTRODUCTION 95
6.2 MANDIBULAR ADVANCEMENT DEVICES 96
6.2.1 READY-MADE MANDIBULAR ADVANCEMENT DEVICES 99
6.2.1.1 Low cost of ready-made MADs to boost demand 99
6.2.2 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES 101
6.2.2.1 High efficacy of custom-made MADs to support market growth 101
6.3 TONGUE-RETAINING DEVICES 103
6.3.1 LOWER SUCCESS RATE OF TRDS TO HINDER MARKET GROWTH 103
6.4 DAYTIME-NIGHTTIME APPLIANCES 105
6.4.1 INCREASING COMFORT & CONVENIENCE TO FUEL MARKET 105
7 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE 106
7.1 INTRODUCTION 107
7.2 PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES 107
7.2.1 FAILURE ASSOCIATED WITH CPAP THERAPY TO BOOST DEMAND 107
7.3 ONLINE OTC ORAL APPLIANCES 110
7.3.1 LACK OF REGULATORY APPROVAL TO HINDER MARKET GROWTH 110
8 SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER 112
8.1 INTRODUCTION 113
8.2 MALE PATIENTS 114
8.2.1 INHERENT DIFFERENCES IN BODY ANATOMY TO FUEL UPTAKE 114
8.3 FEMALE PATIENTS 115
8.3.1 GROWING AWARENESS FOR IMPROVED DIAGNOSIS TO SUPPORT MARKET 115
9 SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP 118
9.1 INTRODUCTION 119
9.2 BELOW 40 YEARS 120
9.2.1 LOWER PREVALENCE OF OSA IN YOUNGER AGE GROUPS TO RESTRAIN MARKET 120
9.3 BETWEEN 40–60 YEARS 121
9.3.1 LIFESTYLE FACTORS TO CONTRIBUTE TO MARKET GROWTH 121
9.4 ABOVE 60 YEARS 123
9.4.1 AGE-ASSOCIATED DISORDERS TO SUPPORT MARKET GROWTH 123
10 SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL 126
10.1 INTRODUCTION 127
10.2 ONLINE PHARMACIES 127
10.2.1 RISING BENEFITS OFFERED BY E-COMMERCE TO PROPEL MARKET 127
10.3 RETAIL PHARMACIES 129
10.3.1 RISING ACCESSIBILITY TO WIDE RANGE OF ORAL APPLIANCES TO BOOST DEMAND 129
10.4 HOSPITAL PHARMACIES & DENTAL CLINICS 131
10.4.1 PROVISION OF MAD AND TRD DEVICES DURING ORAL PROCEDURES TO SUPPORT MARKET GROWTH 131
11 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER 134
11.1 INTRODUCTION 135
11.2 HOME CARE SETTINGS/INDIVIDUALS 135
11.2.1 GROWING PATIENT PREFERENCE FOR REMOTE OSA SERVICES TO PROPEL MARKET 135
11.3 HOSPITALS 137
11.3.1 ABILITY TO PURCHASE ADVANCED SLEEP APNEA EQUIPMENT TO DRIVE MARKET 137
11.4 DENTAL CLINICS 140
11.4.1 INCREASING ESTABLISHMENT OF PRIVATE DENTAL PRACTICES TO SUPPORT MARKET GROWTH 140
12 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION 142
12.1 INTRODUCTION 143
12.2 NORTH AMERICA 143
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 144
12.2.2 US 148
12.2.2.1 Favorable reimbursements and regulatory support to fuel market 148
12.2.3 CANADA 152
12.2.3.1 Increasing number of research grants for awareness of sleep disorders to drive market 152
12.3 EUROPE 155
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 156
12.3.2 GERMANY 159
12.3.2.1 High prevalence of smokers and favorable health insurance coverage to fuel market 159
12.3.3 UK 162
12.3.3.1 Rising awareness among patients and increasing number of sleep service groups to support market 162
12.3.4 FRANCE 165
12.3.4.1 Expanding geriatric population and growing awareness of early diagnosis for OSA to drive market 165
12.3.5 ITALY 168
12.3.5.1 High prevalence of obesity and CVD to fuel market 168
12.3.6 SPAIN 171
12.3.6.1 Growing focus on telemedicine and remote monitoring of OSA patients to drive market 171
12.3.7 REST OF EUROPE 174
12.4 ASIA PACIFIC 177
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 177
12.4.2 CHINA 181
12.4.2.1 Rising geriatric population and increasing cases of obesity to boost demand 181
12.4.3 JAPAN 184
12.4.3.1 Rising demand for cloud-connected sleep apnea therapeutic devices to fuel uptake 184
12.4.4 AUSTRALIA 187
12.4.4.1 Launch of technologically advanced OSA devices to aid market growth 187
12.4.5 REST OF ASIA PACIFIC 190
12.5 LATIN AMERICA 193
12.5.1 POOR HEALTHCARE INFRASTRUCTURE AND LIMITED PUBLIC HEALTH INITIATIVES TO RESTRAIN MARKET 193
12.5.2 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 194
12.6 MIDDLE EAST & AFRICA 197
12.6.1 PRESENCE OF KEY INTERNATIONAL PLAYERS AND HIGH INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET 197
12.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 197
12.7 GCC COUNTRIES 200
12.7.1 HIGH OBESITY RATE AMONG WOMEN TO SUPPORT MARKET GROWTH 200
12.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 201
13 COMPETITIVE LANDSCAPE 204
13.1 OVERVIEW 204
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN 204
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET 204
13.3 REVENUE ANALYSIS, 2022–2024 207
13.4 MARKET SHARE ANALYSIS, 2024 208
13.4.1 RANKING OF KEY MARKET PLAYERS 209
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 210
13.5.1 STARS 210
13.5.2 EMERGING LEADERS 210
13.5.3 PERVASIVE PLAYERS 210
13.5.4 PARTICIPANTS 210
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 212
13.5.5.1 Company footprint 212
13.5.5.2 Region footprint 213
13.5.5.3 Product footprint 214
13.5.5.4 Purchase type footprint 214
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 215
13.6.1 PROGRESSIVE COMPANIES 215
13.6.2 RESPONSIVE COMPANIES 215
13.6.3 DYNAMIC COMPANIES 215
13.6.4 STARTING BLOCKS 215
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 217
13.6.5.1 Detailed list of key startups/SMEs 217
13.6.5.2 Competitive benchmarking of key startups/SMEs 217
13.7 COMPANY VALUATION AND FINANCIAL METRICS 218
13.7.1 COMPANY VALUATION 218
13.7.2 FINANCIAL METRICS 219
13.8 BRAND/PRODUCT COMPARISON 220
13.9 COMPETITIVE SCENARIO 221
13.9.1 PRODUCT LAUNCHES & APPROVALS 221
13.9.2 DEALS 222
13.9.3 EXPANSIONS 223
13.9.4 OTHER DEVELOPMENTS 224
14 COMPANY PROFILES 225
14.1 KEY PLAYERS 225
14.1.1 SOMNOMED 225
14.1.1.1 Business overview 225
14.1.1.2 Products offered 226
14.1.1.3 MnM view 227
14.1.1.3.1 Key strengths 227
14.1.1.3.2 Strategic choices 227
14.1.1.3.3 Weaknesses & competitive threats 227
14.1.2 RESMED 228
14.1.2.1 Business overview 228
14.1.2.2 Products offered 229
14.1.2.2.1 Deals 230
14.1.2.2.2 Expansions 230
14.1.2.3 MnM view 230
14.1.2.3.1 Key strengths 230
14.1.2.3.2 Strategic choices 231
14.1.2.3.3 Weaknesses & competitive threats 231
14.1.3 PROSOMNUS SLEEP TECHNOLOGIES 232
14.1.3.1 Business overview 232
14.1.3.2 Products offered 233
14.1.3.3 Recent developments 233
14.1.3.3.1 Deals 233
14.1.3.4 MnM view 233
14.1.3.4.1 Key strengths 233
14.1.3.4.2 Strategic choices 233
14.1.3.4.3 Weaknesses & competitive threats 234
14.1.4 DYNAFLEX 235
14.1.4.1 Business overview 235
14.1.4.2 Products offered 235
14.1.4.3 Recent developments 236
14.1.4.3.1 Deals 236
14.1.5 VIVOS THERAPEUTICS, INC. 237
14.1.5.1 Business overview 237
14.1.5.2 Products offered 238
14.1.5.3 Recent developments 238
14.1.5.3.1 Product approvals 238
14.1.5.3.2 Deals 239
14.1.5.3.3 Expansions 239
14.1.5.3.4 Other developments 240
14.1.6 OPENAIRWAY 241
14.1.6.1 Business overview 241
14.1.6.2 Products offered 241
14.1.6.3 Recent developments 241
14.1.6.3.1 Deals 241
14.1.7 PANTHERA DENTAL 242
14.1.7.1 Business overview 242
14.1.7.2 Products offered 242
14.1.7.3 Recent developments 243
14.1.7.3.1 Product launches 243
14.1.7.3.2 Deals 243
14.1.7.3.3 Other developments 243
14.1.8 AIRWAY MANAGEMENT 244
14.1.8.1 Business overview 244
14.1.8.2 Products offered 244
14.1.8.3 Recent developments 244
14.1.8.3.1 Product launches 244
14.1.9 APNEA SCIENCES 245
14.1.9.1 Business overview 245
14.1.9.2 Products offered 245
14.1.10 ORAVANOSA 246
14.1.10.1 Business overview 246
14.1.10.2 Products offered 246
14.1.11 MYERSON LLC. 247
14.1.11.1 Business overview 247
14.1.11.2 Products offered 247
14.1.12 BRAEBON MEDICAL CORPORATION 248
14.1.12.1 Business overview 248
14.1.12.2 Products offered 248
14.2 OTHER PLAYERS 249
14.2.1 MPOWRX HEALTH & WELLNESS PRODUCTS 249
14.2.2 THE SNORE RELIEVER COMPANY, LLC 249
14.2.3 TOMED GMBH 250
14.2.4 THE AURUM GROUP 250
14.2.5 ERKODENT ENRICH KOPP GMBH 251
14.2.6 OSCIMED SA 251
14.2.7 SICAT GMBH & CO. KG 252
14.2.8 GLIDEWELL 252
14.2.9 APNOMED, INC. 253
14.2.10 ZQUIET 254
14.2.11 DREAM SYSTEMS DENTAL SLEEP LAB 254
14.2.12 ALIVE MEDICAL SURGICAL EQUIPMENT TRADING LLC 255
14.2.13 ORTHOAPNEA 255
14.2.14 DOC BRANDS, INC. 256
15 APPENDIX 257
15.1 DISCUSSION GUIDE 257
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 261
15.3 CUSTOMIZATION OPTIONS 263
15.4 RELATED REPORTS 263
15.5 AUTHOR DETAILS 264
LIST OF TABLES
TABLE 1 SLEEP APNEA ORAL APPLIANCES MARKET: INCLUSIONS & EXCLUSIONS 29
TABLE 2 SLEEP APNEA ORAL APPLIANCES MARKET: RISK ASSESSMENT ANALYSIS 45
TABLE 3 PREVALENCE OF SLEEP APNEA, BY COUNTRY, 2022−2024 55
TABLE 4 SUPPORTIVE AWARENESS INITIATIVES FOR EFFECTS OF UNTREATED SLEEP APNEA 56
TABLE 5 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR TREATING SLEEP APNEA 57
TABLE 6 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023−2025 (USD) 63
TABLE 7 AVERAGE SELLING PRICE OF SLEEP APNEA ORAL PRODUCTS,
BY KEY PLAYER, 2023−2025 63
TABLE 8 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION, 2023−2025 (USD) 64
TABLE 9 SLEEP APNEA ORAL APPLIANCES MARKET: ROLE IN ECOSYSTEM 67
TABLE 10 SLEEP APNEA ORAL APPLIANCES MARKET: PORTER’S FIVE FORCES ANALYSIS 68
TABLE 11 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 71
TABLE 12 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 72
TABLE 13 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 73
TABLE 14 CHINA: CLASSIFICATION OF MEDICAL DEVICES 74
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 76
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 78
TABLE 19 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 78
TABLE 20 IMPORT DATA FOR INSTRUMENTS & APPLIANCES USED IN DENTAL SCIENCES,
BY COUNTRY, 2020–2024 (USD MILLION) 79
TABLE 21 EXPORT DATA FOR INSTRUMENTS & APPLIANCES USED IN DENTAL SCIENCES,
BY COUNTRY, 2020–2024 (USD MILLION) 79
TABLE 22 SLEEP APNEA ORAL APPLIANCES MARKET: KEY CONFERENCES & EVENTS, 2025−2026 81
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA ORAL APPLIANCES, BY END USERS (%) 83
TABLE 24 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA ORAL APPLIANCES 84
TABLE 25 SLEEP APNEA ORAL APPLIANCES MARKET: END-USER ANALYSIS 88
TABLE 26 SLEEP APNEA ORAL APPLIANCES MARKET: PRODUCT FEATURES AND COMPARATIVE ASSESSMENT 91
TABLE 27 SLEEP APNEA ORAL APPLIANCES MARKET: NEED GAP ANALYSIS 92
TABLE 28 US ADJUSTED RECIPROCAL TARIFF RATES 93
TABLE 29 ORAL APPLIANCES OFFERED BY KEY PLAYERS 95
TABLE 30 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 96
TABLE 31 MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS 96
TABLE 32 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 97
TABLE 33 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 97
TABLE 34 NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 98
TABLE 35 EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 98
TABLE 36 ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 98
TABLE 37 READY-MADE MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS 99
TABLE 38 READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 99
TABLE 39 NORTH AMERICA: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 100
TABLE 40 EUROPE: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 100
TABLE 41 ASIA PACIFIC: READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 100
TABLE 42 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES OFFERED BY KEY PLAYERS 101
TABLE 43 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 101
TABLE 44 NORTH AMERICA: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 102
TABLE 45 EUROPE: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 102
TABLE 46 ASIA PACIFIC: CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 102
TABLE 47 TONGUE-RETAINING DEVICES OFFERED BY KEY PLAYERS 103
TABLE 48 TONGUE-RETAINING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 103
TABLE 49 NORTH AMERICA: TONGUE-RETAINING DEVICES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 104
TABLE 50 EUROPE: TONGUE-RETAINING DEVICES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 104
TABLE 51 ASIA PACIFIC: TONGUE-RETAINING DEVICES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 104
TABLE 52 DAYTIME-NIGHTTIME APPLIANCES MARKET, BY REGION,
2022–2030 (USD MILLION) 105
TABLE 53 NORTH AMERICA: DAYTIME-NIGHTTIME APPLIANCES MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 105
TABLE 54 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE,
2022–2030 (USD MILLION) 107
TABLE 55 PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES OFFERED
BY KEY PLAYERS 108
TABLE 56 PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES MARKET,
BY REGION, 2022–2030 (USD MILLION) 108
TABLE 57 NORTH AMERICA: PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 109
TABLE 58 EUROPE: PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 109
TABLE 59 ASIA PACIFIC: PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 109
TABLE 60 ONLINE OTC ORAL APPLIANCES OFFERED BY KEY PLAYERS 110
TABLE 61 ONLINE OTC ORAL APPLIANCES MARKET, BY REGION, 2022–2030 (USD MILLION) 110
TABLE 62 NORTH AMERICA: ONLINE OTC ORAL APPLIANCES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 111
TABLE 63 EUROPE: ONLINE OTC ORAL APPLIANCES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 111
TABLE 64 ASIA PACIFIC: ONLINE OTC ORAL APPLIANCES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 111
TABLE 65 PREVALENCE OF SLEEP APNEA, BY AGE GROUP & GENDER 113
TABLE 66 SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER,
2022–2030 (USD MILLION) 113
TABLE 67 SLEEP APNEA ORAL APPLIANCES MARKET FOR MALE PATIENTS,
BY REGION, 2022–2030 (USD MILLION) 114
TABLE 68 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR MALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 114
TABLE 69 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR MALE PATIENTS,
BY COUNTRY, 2022–2030 (USD MILLION) 115
TABLE 70 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR MALE PATIENTS,
BY COUNTRY, 2022–2030 (USD MILLION) 115
TABLE 71 SLEEP APNEA ORAL APPLIANCES MARKET FOR FEMALE PATIENTS, BY REGION, 2022–2030 (USD MILLION) 116
TABLE 72 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 116
TABLE 73 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR FEMALE PATIENTS,
BY COUNTRY, 2022–2030 (USD MILLION) 117
TABLE 74 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR FEMALE PATIENTS, BY COUNTRY, 2022–2030 (USD MILLION) 117
TABLE 75 PREVALENCE OF SLEEP APNEA, BY AGE GROUP, 2021 119
TABLE 76 SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP,
2022–2030 (USD MILLION) 119
TABLE 77 SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BELOW 40 YEARS,
BY REGION, 2022–2030 (USD MILLION) 120
TABLE 78 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BELOW 40 YEARS, BY COUNTRY, 2022–2030 (USD MILLION) 120
TABLE 79 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS
BELOW 40 YEARS, BY COUNTRY, 2022–2030 (USD MILLION) 121
TABLE 80 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BELOW 40 YEARS, BY COUNTRY, 2022–2030 (USD MILLION) 121
TABLE 81 SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BETWEEN 40–60 YEARS, BY REGION, 2022–2030 (USD MILLION) 122
TABLE 82 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BETWEEN 40–60 YEARS, BY COUNTRY, 2022–2030 (USD MILLION) 122
TABLE 83 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BETWEEN 40–60 YEARS, BY COUNTRY, 2022–2030 (USD MILLION) 123
TABLE 84 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS BETWEEN 40–60 YEARS, BY COUNTRY, 2022–2030 (USD MILLION) 123
TABLE 85 SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS ABOVE 60 YEARS,
BY REGION, 2022–2030 (USD MILLION) 124
TABLE 86 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022–2030 (USD MILLION) 124
TABLE 87 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022–2030 (USD MILLION) 125
TABLE 88 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR INDIVIDUALS ABOVE 60 YEARS, BY COUNTRY, 2022–2030 (USD MILLION) 125
TABLE 89 SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL,
2022–2030 (USD MILLION) 127
TABLE 90 SLEEP APNEA ORAL APPLIANCES MARKET FOR ONLINE PHARMACIES, BY REGION, 2022–2030 (USD MILLION) 128
TABLE 91 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022–2030 (USD MILLION) 128
TABLE 92 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR ONLINE PHARMACIES,
BY COUNTRY, 2022–2030 (USD MILLION) 129
TABLE 93 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022–2030 (USD MILLION) 129
TABLE 94 SLEEP APNEA ORAL APPLIANCES MARKET FOR RETAIL PHARMACIES, BY REGION, 2022–2030 (USD MILLION) 130
TABLE 95 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022–2030 (USD MILLION) 130
TABLE 96 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR RETAIL PHARMACIES,
BY COUNTRY, 2022–2030 (USD MILLION) 131
TABLE 97 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022–2030 (USD MILLION) 131
TABLE 98 SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITAL PHARMACIES & DENTAL CLINICS, BY REGION, 2022–2030 (USD MILLION) 132
TABLE 99 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITAL PHARMACIES & DENTAL CLINICS, BY COUNTRY, 2022–2030 (USD MILLION) 132
TABLE 100 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITAL PHARMACIES & DENTAL CLINICS, BY COUNTRY, 2022–2030 (USD MILLION) 133
TABLE 101 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITAL PHARMACIES & DENTAL CLINICS, BY COUNTRY, 2022–2030 (USD MILLION) 133
TABLE 102 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2022–2030 (USD MILLION) 135
TABLE 103 SLEEP APNEA ORAL APPLIANCES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY REGION, 2022–2030 (USD MILLION) 136
TABLE 104 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY COUNTRY, 2022–2030 (USD MILLION) 136
TABLE 105 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY COUNTRY, 2022–2030 (USD MILLION) 137
TABLE 106 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY COUNTRY, 2022–2030 (USD MILLION) 137
TABLE 107 SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITALS, BY REGION,
2022–2030 (USD MILLION) 138
TABLE 108 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITALS,
BY COUNTRY, 2022–2030 (USD MILLION) 139
TABLE 109 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION) 139
TABLE 110 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR HOSPITALS,
BY COUNTRY, 2022–2030 (USD MILLION) 139
TABLE 111 SLEEP APNEA ORAL APPLIANCES MARKET FOR DENTAL CLINICS, BY REGION, 2022–2030 (USD MILLION) 140
TABLE 112 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET FOR DENTAL CLINICS, BY COUNTRY, 2022–2030 (USD MILLION) 140
TABLE 113 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET FOR DENTAL CLINICS,
BY COUNTRY, 2022–2030 (USD MILLION) 141
TABLE 114 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET FOR DENTAL CLINICS,
BY COUNTRY, 2022–2030 (USD MILLION) 141
TABLE 115 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION,
2022–2030 (USD MILLION) 143
TABLE 116 NORTH AMERICA: MACROECONOMIC INDICATORS 144
TABLE 117 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 145
TABLE 118 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY,
2022–2030 (THOUSAND UNITS) 146
TABLE 119 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 146
TABLE 120 NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 146
TABLE 121 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER,
2022–2030 (USD MILLION) 147
TABLE 122 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 147
TABLE 123 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 147
TABLE 124 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 148
TABLE 125 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 148
TABLE 126 KEY SLEEP APNEA PRODUCTS CURRENTLY AVAILABLE IN US 149
TABLE 127 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 150
TABLE 128 US: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 150
TABLE 129 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER,
2022–2030 (USD MILLION) 150
TABLE 130 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE,
2022–2030 (USD MILLION) 151
TABLE 131 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP,
2022–2030 (USD MILLION) 151
TABLE 132 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 151
TABLE 133 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2022–2030 (USD MILLION) 152
TABLE 134 KEY SLEEP APNEA PRODUCTS CURRENTLY AVAILABLE IN CANADA 153
TABLE 135 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 153
TABLE 136 CANADA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 153
TABLE 137 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER,
2022–2030 (USD MILLION) 154
TABLE 138 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE,
2022–2030 (USD MILLION) 154
TABLE 139 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP,
2022–2030 (USD MILLION) 154
TABLE 140 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION
CHANNEL, 2022–2030 (USD MILLION) 155
TABLE 141 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2022–2030 (USD MILLION) 155
TABLE 142 EUROPE: MACROECONOMIC INDICATORS 156
TABLE 143 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 156
TABLE 144 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 157
TABLE 145 EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 157
TABLE 146 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER,
2022–2030 (USD MILLION) 157
TABLE 147 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE,
2022–2030 (USD MILLION) 158
TABLE 148 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP,
2022–2030 (USD MILLION) 158
TABLE 149 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 158
TABLE 150 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2022–2030 (USD MILLION) 159
TABLE 151 KEY SLEEP APNEA PRODUCTS CURRENTLY AVAILABLE IN GERMANY 160
TABLE 152 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 160
TABLE 153 GERMANY: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 160
TABLE 154 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER,
2022–2030 (USD MILLION) 161
TABLE 155 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE,
2022–2030 (USD MILLION) 161
TABLE 156 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP,
2022–2030 (USD MILLION) 161
TABLE 157 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 162
TABLE 158 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2022–2030 (USD MILLION) 162
TABLE 159 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 163
TABLE 160 UK: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 163
TABLE 161 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER,
2022–2030 (USD MILLION) 164
TABLE 162 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE,
2022–2030 (USD MILLION) 164
TABLE 163 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP,
2022–2030 (USD MILLION) 164
TABLE 164 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 165
TABLE 165 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2022–2030 (USD MILLION) 165
TABLE 166 LEADING MARKET PLAYERS & PRODUCTS REIMBURSED BY SOCIAL
SECURITY OF FRANCE 166
TABLE 167 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 166
TABLE 168 FRANCE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 166
TABLE 169 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER,
2022–2030 (USD MILLION) 167
TABLE 170 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE,
2022–2030 (USD MILLION) 167
TABLE 171 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP,
2022–2030 (USD MILLION) 167
TABLE 172 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 168
TABLE 173 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2022–2030 (USD MILLION) 168
TABLE 174 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 169
TABLE 175 ITALY: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 169
TABLE 176 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER,
2022–2030 (USD MILLION) 169
TABLE 177 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE,
2022–2030 (USD MILLION) 170
TABLE 178 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP,
2022–2030 (USD MILLION) 170
TABLE 179 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 170
TABLE 180 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2022–2030 (USD MILLION) 171
TABLE 181 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 172
TABLE 182 SPAIN: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 172
TABLE 183 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER,
2022–2030 (USD MILLION) 172
TABLE 184 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE,
2022–2030 (USD MILLION) 173
TABLE 185 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP,
2022–2030 (USD MILLION) 173
TABLE 186 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 173
TABLE 187 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2022–2030 (USD MILLION) 174
TABLE 188 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 174
TABLE 189 REST OF EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 175
TABLE 190 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER,
2022–2030 (USD MILLION) 175
TABLE 191 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET,
BY PURCHASE TYPE, 2022–2030 (USD MILLION) 175
TABLE 192 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET,
BY AGE GROUP, 2022–2030 (USD MILLION) 176
TABLE 193 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 176
TABLE 194 REST OF EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2022–2030 (USD MILLION) 176
TABLE 195 ASIA PACIFIC: MACROECONOMIC INDICATORS 177
TABLE 196 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 179
TABLE 197 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 179
TABLE 198 ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 179
TABLE 199 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER,
2022–2030 (USD MILLION) 180
TABLE 200 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 180
TABLE 201 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP,
2022–2030 (USD MILLION) 180
TABLE 202 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 181
TABLE 203 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2022–2030 (USD MILLION) 181
TABLE 204 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 182
TABLE 205 CHINA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 182
TABLE 206 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER,
2022–2030 (USD MILLION) 183
TABLE 207 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE,
2022–2030 (USD MILLION) 183
TABLE 208 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP,
2022–2030 (USD MILLION) 183
TABLE 209 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 184
TABLE 210 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2022–2030 (USD MILLION) 184
TABLE 211 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 185
TABLE 212 JAPAN: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 185
TABLE 213 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER,
2022–2030 (USD MILLION) 185
TABLE 214 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE,
2022–2030 (USD MILLION) 186
TABLE 215 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP,
2022–2030 (USD MILLION) 186
TABLE 216 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 186
TABLE 217 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2022–2030 (USD MILLION) 187
TABLE 218 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 188
TABLE 219 AUSTRALIA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 188
TABLE 220 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER,
2022–2030 (USD MILLION) 188
TABLE 221 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 189
TABLE 222 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP,
2022–2030 (USD MILLION) 189
TABLE 223 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 189
TABLE 224 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2022–2030 (USD MILLION) 190
TABLE 225 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET,
BY PRODUCT, 2022–2030 (USD MILLION) 191
TABLE 226 REST OF ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 191
TABLE 227 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET,
BY GENDER, 2022–2030 (USD MILLION) 191
TABLE 228 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET,
BY PURCHASE TYPE, 2022–2030 (USD MILLION) 192
TABLE 229 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET,
BY AGE GROUP, 2022–2030 (USD MILLION) 192
TABLE 230 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET,
BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 192
TABLE 231 REST OF ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET,
BY END USER, 2022–2030 (USD MILLION) 193
TABLE 232 LATIN AMERICA: MACROECONOMIC INDICATORS 194
TABLE 233 LATIN AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 194
TABLE 234 LATIN AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 195
TABLE 235 LATIN AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER,
2022–2030 (USD MILLION) 195
TABLE 236 LATIN AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 195
TABLE 237 LATIN AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 196
TABLE 238 LATIN AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 196
TABLE 239 LATIN AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2022–2030 (USD MILLION) 196
TABLE 240 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 197
TABLE 241 MIDDLE EAST & AFRICA: SLEEP APNEA ORAL APPLIANCES MARKET,
BY PRODUCT, 2022–2030 (USD MILLION) 198
TABLE 242 MIDDLE EAST & AFRICA: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 198
TABLE 243 MIDDLE EAST & AFRICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER, 2022–2030 (USD MILLION) 198
TABLE 244 MIDDLE EAST & AFRICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2022–2030 (USD MILLION) 199
TABLE 245 MIDDLE EAST & AFRICA: SLEEP APNEA ORAL APPLIANCES MARKET,
BY AGE GROUP, 2022–2030 (USD MILLION) 199
TABLE 246 MIDDLE EAST & AFRICA: SLEEP APNEA ORAL APPLIANCES MARKET,
BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 199
TABLE 247 MIDDLE EAST & AFRICA: SLEEP APNEA ORAL APPLIANCES MARKET,
BY END USER, 2022–2030 (USD MILLION) 200
TABLE 248 GCC COUNTRIES: MACROECONOMIC INDICATORS 201
TABLE 249 GCC COUNTRIES: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 201
TABLE 250 GCC COUNTRIES: MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 202
TABLE 251 GCC COUNTRIES: SLEEP APNEA ORAL APPLIANCES MARKET,
BY GENDER, 2022–2030 (USD MILLION) 202
TABLE 252 GCC COUNTRIES: SLEEP APNEA ORAL APPLIANCES MARKET,
BY PURCHASE TYPE, 2022–2030 (USD MILLION) 202
TABLE 253 GCC COUNTRIES: SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 203
TABLE 254 GCC COUNTRIES: SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL, 2022–2030 (USD MILLION) 203
TABLE 255 GCC COUNTRIES: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2022–2030 (USD MILLION) 203
TABLE 256 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET 204
TABLE 257 SLEEP APNEA ORAL APPLIANCES MARKET: DEGREE OF COMPETITION 208
TABLE 258 SLEEP APNEA ORAL APPLIANCES MARKET: REGION FOOTPRINT 213
TABLE 259 SLEEP APNEA ORAL APPLIANCES MARKET: PRODUCT FOOTPRINT 214
TABLE 260 SLEEP APNEA ORAL APPLIANCES MARKET: PURCHASE TYPE FOOTPRINT 214
TABLE 261 SLEEP APNEA ORAL APPLIANCES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 217
TABLE 262 SLEEP APNEA ORAL APPLIANCES MARKET: COMPETITIVE BENCHMARKING
OF KEY START-UPS/SMES 217
TABLE 263 SLEEP APNEA ORAL APPLIANCES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025 221
TABLE 264 SLEEP APNEA ORAL APPLIANCES MARKET: DEALS, JANUARY 2021–APRIL 2025 222
TABLE 265 SLEEP APNEA ORAL APPLIANCES MARKET: EXPANSIONS,
JANUARY 2021–APRIL 2025 223
TABLE 266 SLEEP APNEA ORAL APPLIANCES MARKET: OTHER DEVELOPMENTS, JANUARY 2021–APRIL 2025 224
TABLE 267 SOMNOMED: COMPANY OVERVIEW 225
TABLE 268 SOMNOMED: PRODUCTS OFFERED 226
TABLE 269 RESMED: COMPANY OVERVIEW 228
TABLE 270 RESMED: PRODUCTS OFFERED 229
TABLE 271 RESMED: DEALS, JANUARY 2021–APRIL 2025 230
TABLE 272 RESMED: EXPANSIONS, JANUARY 2021–APRIL 2025 230
TABLE 273 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY OVERVIEW 232
TABLE 274 PROSOMNUS SLEEP TECHNOLOGIES: PRODUCTS OFFERED 233
TABLE 275 PROSOMNUS SLEEP TECHNOLOGIES: DEALS, JANUARY 2021–APRIL 2025 233
TABLE 276 DYNAFLEX: COMPANY OVERVIEW 235
TABLE 277 DYNAFLEX: PRODUCTS OFFERED 235
TABLE 278 DYNAFLEX: DEALS, JANUARY 2021–APRIL 2025 236
TABLE 279 VIVOS THERAPEUTICS, INC.: COMPANY OVERVIEW 237
TABLE 280 VIVOS THERAPEUTICS, INC.: PRODUCTS OFFERED 238
TABLE 281 VIVOS THERAPEUTICS, INC.: PRODUCT APPROVALS, JANUARY 2021–APRIL 2025 238
TABLE 282 VIVOS THERAPEUTICS, INC.: DEALS, JANUARY 2021–APRIL 2025 239
TABLE 283 VIVOS THERAPEUTICS, INC.: EXPANSIONS, JANUARY 2021–APRIL 2025 239
TABLE 284 VIVOS THERAPEUTICS, INC.: OTHER DEVELOPMENTS, JANUARY 2021–APRIL 2025 240
TABLE 285 OPENAIRWAY: COMPANY OVERVIEW 241
TABLE 286 OPENAIRWAY: PRODUCTS OFFERED 241
TABLE 287 OPENAIRWAY: DEALS, JANUARY 2021–APRIL 2025 241
TABLE 288 PANTHERA DENTAL: COMPANY OVERVIEW 242
TABLE 289 PANTHERA DENTAL: PRODUCTS OFFERED 242
TABLE 290 PANTHERA DENTAL: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 243
TABLE 291 PANTHERA DENTAL: DEALS, JANUARY 2021–APRIL 2025 243
TABLE 292 PANTHERA DENTAL: OTHER DEVELOPMENTS, JANUARY 2021–APRIL 2025 243
TABLE 293 AIRWAY MANAGEMENT: COMPANY OVERVIEW 244
TABLE 294 AIRWAY MANAGEMENT: PRODUCTS OFFERED 244
TABLE 295 AIRWAY MANAGEMENT: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 244
TABLE 296 APNEA SCIENCES: COMPANY OVERVIEW 245
TABLE 297 APNEA SCIENCES: PRODUCTS OFFERED 245
TABLE 298 ORAVANOSA: COMPANY OVERVIEW 246
TABLE 299 ORAVANOSA: PRODUCTS OFFERED 246
TABLE 300 MYERSON LLC.: COMPANY OVERVIEW 247
TABLE 301 MYERSON LLC.: PRODUCTS OFFERED 247
TABLE 302 BRAEBON MEDICAL CORPORATION: COMPANY OVERVIEW 248
TABLE 303 BRAEBON MEDICAL CORPORATION: PRODUCTS OFFERED 248
TABLE 304 MPOWRX HEALTH & WELLNESS PRODUCTS: COMPANY OVERVIEW 249
TABLE 305 THE SNORE RELIEVER COMPANY, LLC.: COMPANY OVERVIEW 249
TABLE 306 TOMED GMBH: COMPANY OVERVIEW 250
TABLE 307 THE AURUM GROUP: COMPANY OVERVIEW 250
TABLE 308 ERKODENT ENRICH KOPP GMBH: COMPANY OVERVIEW 251
TABLE 309 OSCIMED SA: COMPANY OVERVIEW 251
TABLE 310 SICAT GMBH & CO.KG: COMPANY OVERVIEW 252
TABLE 311 GLIDEWELL: COMPANY OVERVIEW 252
TABLE 312 APNOMED, INC.: COMPANY OVERVIEW 253
TABLE 313 ZQUIET: COMPANY OVERVIEW 254
TABLE 314 DREAM SYTEMS DENTAL SLEEP LAB: COMPANY OVERVIEW 254
TABLE 315 ALIVE MEDICAL SURGICAL EQUIPMENT TRADING LLC: COMPANY OVERVIEW 255
TABLE 316 ORTHOAPNEA: COMPANY OVERVIEW 255
TABLE 317 DOC BRANDS, INC.: COMPANY OVERVIEW 256
LIST OF FIGURES
FIGURE 1 MARKETS & REGIONS COVERED 30
FIGURE 2 SLEEP APNEA ORAL APPLIANCES MARKET: RESEARCH DESIGN 32
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 38
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 39
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 40
FIGURE 6 SLEEP APNEA ORAL APPLIANCES MARKET: TOP-DOWN APPROACH 41
FIGURE 7 DATA TRIANGULATION METHODOLOGY 42
FIGURE 8 SLEEP APNEA ORAL APPLIANCES MARKET: IMPACT ANALYSIS 44
FIGURE 9 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2025 VS. 2030 (USD MILLION) 46
FIGURE 10 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE,
2025 VS. 2030 (USD MILLION) 47
FIGURE 11 SLEEP APNEA ORAL APPLIANCES MARKET, BY GENDER,
2025 VS. 2030 (USD MILLION) 47
FIGURE 12 SLEEP APNEA ORAL APPLIANCES MARKET, BY AGE GROUP,
2025 VS. 2030 (USD MILLION) 48
FIGURE 13 SLEEP APNEA ORAL APPLIANCES MARKET, BY DISTRIBUTION CHANNEL,
2025 VS. 2030 (USD MILLION) 49
FIGURE 14 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2025 VS. 2030 (USD MILLION) 49
FIGURE 15 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION,
2025 VS. 2030 (USD MILLION) 50
FIGURE 16 LARGE POOL OF UNDIAGNOSED SLEEP APNEA PATIENTS TO DRIVE MARKET 51
FIGURE 17 MANDIBULAR ADVANCEMENT DEVICES SEGMENT TO REGISTER
HIGHEST CAGR DURING FORECAST PERIOD 52
FIGURE 18 MANDIBULAR ADVANCEMENT DEVICES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN US IN 2024 53
FIGURE 19 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 53
FIGURE 20 SLEEP APNEA ORAL APPLIANCES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
FIGURE 21 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING & ASSEMBLY PHASES 65
FIGURE 22 SUPPLY CHAIN ANALYSIS: DIRECT DISTRIBUTION IS THE PREFERRED STRATEGY OF PROMINENT COMPANIES 66
FIGURE 23 SLEEP APNEA ORAL APPLIANCES MARKET: ECOSYSTEM ANALYSIS 67
FIGURE 24 SLEEP APNEA ORAL APPLIANCES MARKET: PORTER’S FIVE FORCES ANALYSIS 68
FIGURE 25 SLEEP APNEA ORAL APPLIANCES MARKET: PATENT ANALYSIS,
JANUARY 2015–DECEMBER 2023 80
FIGURE 26 SLEEP APNEA ORAL APPLIANCES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP
APNEA ORAL APPLIANCES 83
FIGURE 28 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA ORAL APPLIANCES 84
FIGURE 29 AI USE CASES 86
FIGURE 30 SLEEP APNEA ORAL APPLIANCES MARKET: INVESTMENT & FUNDING SCENARIO 2019−2024 87
FIGURE 31 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET SNAPSHOT 145
FIGURE 32 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET SNAPSHOT 178
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET, 2022−2024 (USD MILLION) 207
FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET (2024) 208
FIGURE 35 RANKING OF KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET, 2024 209
FIGURE 36 SLEEP APNEA ORAL APPLIANCES MARKET: COMPANY EVALUATION
MATRIX (KEY PLAYERS), 2024 211
FIGURE 37 SLEEP APNEA ORAL APPLIANCES MARKET: COMPANY FOOTPRINT 212
FIGURE 38 SLEEP APNEA ORAL APPLIANCES MARKET: COMPANY EVALUATION MATRIX
(START-UPS/SMES), 2024 216
FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS 218
FIGURE 40 EV/EBITDA OF KEY VENDORS 219
FIGURE 41 SLEEP APNEA ORAL APPLIANCES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 220
FIGURE 42 SOMNOMED: COMPANY SNAPSHOT (2024) 226
FIGURE 43 RESMED: COMPANY SNAPSHOT (2023) 229
FIGURE 44 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY SNAPSHOT (2023) 232
FIGURE 45 VIVOS THERAPEUTICS, INC.: COMPANY SNAPSHOT (2024) 237
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11